Operator
Good morning. My name is Kaylee, and I ll be your conference operator today. At this time, I would like to welcome everyone to Provention Bio call. [Operator Instructions] Please be advised that this call is being recorded at the company s request.
I would now like to hand the conference over to Mr. Robert Doody, Vice President of Investor Relations for Provention Bio.
Robert A. Doody
Investor Relation
Thank you operator, and thank you all for joining us on Provention Bio s first quarter 2021 financial results conference call. Joining today s call from Provention Bio team is Ashleigh Palmer, Chief Executive Officer and Co-Founder; Andrew Drechsler, Chief Financial Officer; and the other members of the Provention Bio leadership team. Before we begin, let me remind you that the various remarks we will make today constitute forward-looking statements. These include statements about our future expectations, clinical results, regulatory and other developments and timeline
Today, the 2020 California Citizens Redistricting Commission (Commission) announced the approval of HaystaqDNA and Q2 Data & Research, LLC as the contractors selected to assist in the professional and technical drawing of district lines. The Commission is tasked with mapping new districts based on the 2020 Census in conformity with strict, non-partisan rules put in place to ensure fair representation for all Californians. HaystaqDNA and Q2 Data & Research, LLC served as technical consultants to the Arizona and California independent redistricting commissions, respectively, in 2011.
The line drawing team will introduce itself at the Commission’s Thursday, April 1st, 2021 meeting, which will start at 9:30 AM. A link to the live webcast can be found at http://videossc.com/CRC/.
2020 California Citizens Redistricting Commission announces redistricting line-drawing contract thedesertreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedesertreview.com Daily Mail and Mail on Sunday newspapers.
Provention Bio to Present at Two Upcoming Virtual Investor Conferences
News provided by
Share this article
Share this article
RED BANK, N.J., March 4, 2021 /PRNewswire/ Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in two upcoming virtual investor conferences in March.
H.C. Wainwright Global Life Sciences Conference
Andrew Drechsler, Provention Bio s Chief Financial Officer will provide a corporate update at the H.C. Wainwright Global Life Sciences Conference. The webcast will be available beginning Tuesday, March 9, 2021, at 7:00 am E.T and can be accessed by visiting the Events and Webcasts section of the Company s website: http://investors.proventionbio.com/events.